Investing in Canadian Marijuana Stocks

The Canadian marijuana sector is one of the hottest growing sectors. Here's a look at Canadian cannabis companies for investors to consider.

November 16, 2017
Canadian marijuana stocks

The Canadian cannabis sector is taking huge steps in establishing guidelines for their product and finding international opportunities in the medical landscape, while the recreational market will officially be legalized come July 1, 2018.

Down in the US, a number of states are in various phases of legalization for both medical and recreational marijuana use. Similarly, while it’s still well over a year until recreational use is legalized in Canada, this can make the market confusing, or even a little risky, for new investors. That said, there are good opportunities out there for those willing to do their research.

Business in cannabis has expanded into massive levels of investment thanks to opportunities in various stock listings. In Canada, cannabis companies can seek public investment through stock listings on the Toronto Stock Exchange, its smaller sibling market Toronto Stock Venture and the Canadian Securities Exchange.

With that in mind, here’s a look at a variety of publicly traded Canadian marijuana stocks. The list includes cannabis and hemp focused stocks listed on Canadian exchanges. Be sure to click on the title of the lists in order to see the complete lists on different pages.

Ready to invest in Cannabis? 

TSX Cannabis Stocks
The TSX has seen leaders of the cannabis industry join its listing and offer investors a new venue into cannabis ventures. These include massive license producers (LPs) expanding their product and brands overseas.

Aphria (TSX:APH)
Also licensed under the ACMPR, much like other companies on the Canadian marijuana stocks, Aphria is located in Leamington, Ontario. The company self-describes itself as “truly powered by sunlight”, which they state allows for natural growing conditions to produce safe medical cannabis products.

Aphria made its strategic entrance to the US cannabis market through Liberty Health Sciences, which seeks and partners with cannabis companies in the US. Their first market is in Florida.

Canopy Growth (TSX:WEED)
Canopy Growth is the largest Canadian marijuana stocks company, having been the first cannabis organization to surpass the $1 billion market cap.

Canopy holds producers Tweed and Bedrocan under its umbrella. Tweed’s production facility is located in the old Hershey factory in Smith Falls, Ontario, while its breeding facility was completed in September 2016. The company believes the state-of-the-art facility is the first of its kind and will form the foundation of new Canadian-bred genetics.

Canopy regularly announces new deals and partnerships with international emerging markets. Late in 2017, the company announced a deal with Constellation Brands (NYSE:STZ), a massive alcohol producer in the US, for 9.9 percent equity of Canopy, which signaled the increased credibility of the cannabis business to the overall market.

TSXV Cannabis Stocks
Previously known as the Canadian Venture Exchange, the TSX Venture Exchange is the sibling listing from the larger Toronto Stock Exchange. This listing offers a variety of cannabis-related businesses from growers to biotech companies looking for cannabinoid (CBD) therapies.

Cannabis Wheaton Income (TSXV:CBW)
A fairly new entrant to the Canadian cannabis sector, Cannabis Wheaton, was formed to provide funding for facility expansions, operations, and initial construction. In return, the company gets minority equity interests and a percentage of the cultivation. Their team includes a group of experienced people in the area like the co-founder of Canopy, Chuck Rifici, who is the CEO of Cannabis Wheaton.

President Hugo Alves told INN the company overcame an unsuccessful offering deal with two financial banking institutions to continue their financing business with other cannabis businesses in Canada.

Supreme Pharmaceuticals (TSXV:SL)
Supreme Pharmaceuticals is next on our Canadian marijuana stocks list. Located in Kincardine, Ontario, the company’s federally approved medical marijuana company, 7ACRES, cultivates medical marijuana on a greenhouse cost base. Along with 24 other companies, Supreme received its federal license in March of 2016.

In October the company announced its partner 7ACRES obtained Health Canada approvals in order to start cultivation at the recently completed 30,000 square feet flowering rooms at their hybrid facility.

CSE Cannabis Stocks
The Canadian Securities Exchange (CSE) offers investors with a variety of cannabis-related companies seeking to increase their business activities. The CSE offers Canadian companies an option to seek business possibilities in the US, as long as it manages to disclose all its risks properly to shareholders.

Beleave (CSE:BE)
Beleave is a biotech company with a focus on becoming a licensed producer of medical-grade cannabis under the ACMPR. Its wholly-owned subsidiary, First Access, applied for a pre-license inspection in March 2017.

Recently the company announced a shift in management when Andrew Wnek stepped into the role of CEO as Dr. Roger Ferreira moved into the role of chief science officer.

In June the company announced it had started the cultivation at their facility located in Hamilton, Ontario. The harvest for these crops was completed in September and the company then applied for a license to sell dried cannabis.

MPX Bioceutical Corporation (CSE:BCC)
Through its subsidiaries and investments in several states in the US, MPX Bioceutical Corporation is involved in the American cannabis market. Formerly known as Canadian Bioceutical Corporation, the company officially changed its name in November.

The company applied for a Canadian licensed producer (LP) status, but due to a rocky unresponsive process decided to mobilize its investments in the US. On May 22, 2017, the company officially began trading on the OTCQB Market.

This article has been updated since its original publication in 2016, with the most recent update done by Bryan Mc Govern.